Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study

J Clin Psychopharmacol. 2008 Jun;28(3):349-52. doi: 10.1097/JCP.0b013e318172755a.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amisulpride
  • Antipsychotic Agents / administration & dosage*
  • Antipsychotic Agents / adverse effects*
  • Aripiprazole
  • Comorbidity
  • Dopamine Antagonists / administration & dosage*
  • Dopamine Antagonists / adverse effects
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Middle Aged
  • Obsessive-Compulsive Disorder / chemically induced*
  • Obsessive-Compulsive Disorder / diagnosis
  • Obsessive-Compulsive Disorder / drug therapy*
  • Obsessive-Compulsive Disorder / psychology
  • Piperazines / administration & dosage
  • Piperazines / adverse effects*
  • Prospective Studies
  • Psychiatric Status Rating Scales
  • Quinolones / administration & dosage
  • Quinolones / adverse effects*
  • Risperidone / administration & dosage
  • Risperidone / adverse effects*
  • Schizophrenia / diagnosis
  • Schizophrenia / drug therapy*
  • Schizophrenic Psychology*
  • Sulpiride / administration & dosage
  • Sulpiride / adverse effects
  • Sulpiride / analogs & derivatives*
  • Treatment Outcome

Substances

  • Antipsychotic Agents
  • Dopamine Antagonists
  • Piperazines
  • Quinolones
  • Sulpiride
  • Amisulpride
  • Aripiprazole
  • Risperidone